[Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology]
- PMID: 172838
[Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology]
Abstract
In ten patients with Paget's disease of bone (Group I) intramuscular injection of 50 MRC units of synthetic Salmon calcitonin (SCT) induced a marked decrease of serum calcium (-1,444 mg%), serum phosphorus (-1,06 mg%), urinary total hydroxyproline (-71%), and a marked increase of urinary cyclic AMP (+ 114%). These changes occur at maximum 6 hours after the injection with a return to the initial values after 24 hours. In six other patients with Paget's disease (Group II) the acute biological effects were of the same nature and magnitude after the injection of 100 MRC units of SCT. In this group a significant but temporary increase of the plasma parathyroid hormone level was demonstrated. The magnitude of the hypocalcemia seems proportional to the initial serum alkaline phosphatase and urinary hydroxyproline levels. After one month of treatment, the alkaline phosphatase and urinary hydroxyproline have more marked and more regular decrease in group II who received 100 MRC units of SCT daily than in group I who received 50 MRC units three times a week. The cellular mechanisms of these biological changes are discussed. A posology of two daily injections of 50 MRC units of SCT is suggested when a quick and maximum stoppage of pagetic remodeling is required.
Similar articles
-
[Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].Minerva Med. 1983 Apr 28;74(18):993-1010. Minerva Med. 1983. PMID: 6087215 Italian.
-
[A test for acute hypocalcemia using swine and salmon calcitonin].Rev Rhum Mal Osteoartic. 1977 Feb;44(2):91-8. Rev Rhum Mal Osteoartic. 1977. PMID: 847364 French.
-
Long-term treatment of Paget's disease of bone with salmon calcitonin.Can Med Assoc J. 1977 Nov 5;117(9):1031-4. Can Med Assoc J. 1977. PMID: 562231 Free PMC article.
-
Calcitonin in the treatment of Paget's disease of bone.Ann Intern Med. 1972 Apr;76(4):665-6. doi: 10.7326/0003-4819-76-4-665_2. Ann Intern Med. 1972. PMID: 4268241 Review. No abstract available.
-
Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).Clin Orthop Relat Res. 1977;(127):94-105. Clin Orthop Relat Res. 1977. PMID: 410576 Review. No abstract available.
Cited by
-
Failure of oral calcium to enhance the acute antiosteolytic effect of calcitonin.Calcif Tissue Int. 1987 Feb;40(2):114-5. doi: 10.1007/BF02555715. Calcif Tissue Int. 1987. PMID: 3105833 No abstract available.
-
Acute antiosteoclastic effect of salmon calcitonin in osteoporotic women.Calcif Tissue Int. 1986 Feb;38(2):71-5. doi: 10.1007/BF02556832. Calcif Tissue Int. 1986. PMID: 3082496